Muscle Relaxant Drugs Market Size

Muscle Relaxant Drugs Market size was valued at USD 3.43 million in 2024 and is poised to cross USD 8.06 million by the end of 2037, registering more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of muscle relaxant drugs is estimated at USD 3.62 million.

The growth of the market can primarily be attributed to the rising number of populations suffering from musculoskeletal conditions worldwide, along with patients with lower back pain. As per recent statistics provided by the Global Burden of Disease (GBD) in the year 2019, more than 1.71 billion people live with musculoskeletal conditions around the globe.

A common problem noticed worldwide is deteriorating muscle health and an increase in muscle spasms. An upsurge in problems such as muscle cramps, sprains and strains, fibromyalgia, tendinitis, neuromuscular disorders, and many more diseases has been observed worldwide.